ArticleCancer science2017
Survivin: A novel marker and potential therapeutic target for human angiosarcoma.
Masayuki Tsuneki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it
ArticleCancer science2017
Masayuki Tsuneki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.